Avastin's Failure in Breast Cancer: New Study May Explain Why It Happened


January 30, 2012

My Health News Daily

Celeste Simon, PhD, scientific director, Abramson Family Cancer Research Institute and professor of Cell and Developmental Biology, comments in MyHealthNewsDaily.com about a new study that may explain why the cancer drug Avastin hasn't worked in the treatment of breast cancer patients. Although Avastin, when initially given, causes some cancer cells to die and tumors to shrink, what's left behind are cancer stem cells. "Stem cells really like to reside in a low-oxygen area," Simon said. What the study adds is evidence that drugs like Avastin increase the pool of cancer stem cells living in low-oxygen parts of tumors... Read More